[HTML][HTML] Electroconvulsive therapy in catatonic patients: efficacy and predictors of response
F Luchini, P Medda, MG Mariani, M Mauri… - World journal of …, 2015 - ncbi.nlm.nih.gov
Recent evidence favors the view of catatonia as an autonomous syndrome, frequently
associated with mood disorders, but also observed in neurological, neurodevelopmental …
associated with mood disorders, but also observed in neurological, neurodevelopmental …
Rapid treatments for depression: endocannabinoid system as a therapeutic target
Current first-line treatments for major depressive disorder (MDD), ie, antidepressant drugs
and psychotherapy, show delayed onset of therapeutic effect as late as 2–3 weeks or more …
and psychotherapy, show delayed onset of therapeutic effect as late as 2–3 weeks or more …
[HTML][HTML] Guidelines on muscle relaxants and reversal in anaesthesia
B Plaud, C Baillard, JL Bourgain, G Bouroche… - … Critical Care & Pain …, 2020 - Elsevier
Objectives To provide an update to the 1999 French guidelines on “Muscle relaxants and
reversal in anaesthesia”, a consensus committee of sixteen experts was convened. A formal …
reversal in anaesthesia”, a consensus committee of sixteen experts was convened. A formal …
Medication management during electroconvulsant therapy
M Zolezzi - Neuropsychiatric disease and treatment, 2016 - Taylor & Francis
Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life
saving for many psychiatric disorders such as major depression, bipolar disorder and …
saving for many psychiatric disorders such as major depression, bipolar disorder and …
A narrative overview of current anesthetic drugs in electroconvulsive therapy
Electroconvulsive therapy (ECT) is a definitive treatment for patients with psychiatric
disorders that are severe, acute, or refractory to pharmacologic therapy. Providing …
disorders that are severe, acute, or refractory to pharmacologic therapy. Providing …
Electroconvulsive therapy: recent advances and anesthetic considerations
T Ninke, P Groene - Current Opinion in Anesthesiology, 2023 - journals.lww.com
ECT is effective in treating treatment-resistant psychiatric illnesses. Symptoms of cognitive
impairment are the most common side effects but can be treated by modifying the technique …
impairment are the most common side effects but can be treated by modifying the technique …
Minimum effective doses of succinylcholine and rocuronium during electroconvulsive therapy: a prospective, randomized, crossover trial
H Mirzakhani, HJ Guchelaar, CA Welch… - Anesthesia & …, 2016 - journals.lww.com
BACKGROUND: Neuromuscular blockade is required to control excessive muscle
contractions during electroconvulsive therapy (ECT). In a crossover, assessor-blinded …
contractions during electroconvulsive therapy (ECT). In a crossover, assessor-blinded …
Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression?
V Saricicek, L Sahin, F Bulbul, S Ucar… - The Journal of ECT, 2014 - journals.lww.com
Background We aimed to compare the effects of succinylcholine and rocuronium-
sugammadex on development of myalgia and headache after electroconvulsive therapy …
sugammadex on development of myalgia and headache after electroconvulsive therapy …
Prevalence and associated factors of postoperative suxamethonium-induced myalgia in surgical patients at Debre Tabor Comprehensive Specialized Hospital …
B Chekol, N Zurbachew, G Mekete, E Bayuh… - Scientific Reports, 2024 - nature.com
Suxamethonium is considered by many to be the best drug for providing ideal intubating
conditions, short surgical procedures, and rapid sequence induction. However, its …
conditions, short surgical procedures, and rapid sequence induction. However, its …
米库氯铵与罗库溴铵用于麻醉诱导时插管条件及安全性比较
王敏， 刘毅， 米卫东 - 解放军医学院学报, 2013 - xuebao.301hospital.com.cn
目的比较静脉麻醉使用罗库溴铵或米库氯铵行气管内插管时的插管条件及安全性. 方法2012 年3-
6 月在我院择期行耳鼻喉科手术患者40 例, 随机分为两组, 每组各20 例, 给予罗库溴铵0.6 mg/kg …
6 月在我院择期行耳鼻喉科手术患者40 例, 随机分为两组, 每组各20 例, 给予罗库溴铵0.6 mg/kg …